US Patent Issued to SyzygyMed on May 12 for "Genetically engineered hematopoietic stem cells and uses thereof" (Massachusetts, Illinois Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,929, issued on May 12, was assigned to SyzygyMed Inc. (Anacortes, Wash.).

"Genetically engineered hematopoietic stem cells and uses thereof" was invented by Joseph Bolen (Boston), Aleksandar Filip Radovic-Moreno (Evanston, Ill.) and John Lydeard (Sharon, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins."

The patent was filed on May 31, 2022, under Appl...